At the recent Biotherapeutics Analytical Summit, Fredrik Sundberg presented the importance of implementation of a robust analytical control strategy to ensure drug product efficacy and patient safety. He also covered the latest regulatory strategies and a new assay validation guideline for surface plasmon resonance (SPR) technology.
Sign up to access and to view an on-demand recording.